Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Why did I, invest in PTSC?

Hmmmm.... But at what percentage would they now split the J3 MOU monies? That percentage that was at the time of the settlement, or that which will result from the lawsuit remedy?

Isn't that rather like asking what percentage TPL will receive on future fees currently under negotiation?

If the Court amends the percentage distribution, wouldn't it be only effective going forward ie fees received after the amendment?

.

.

.

Be well

Share
New Message
Please login to post a reply